Skip to main content

Progressive Supranuclear Palsy

  • Chapter
  • First Online:
Case-based Approach to Common Neurological Disorders

Abstract

A 60-year-old man presented with a 2-year history of progressive difficulty in walking, with occasional unprovoked falls, especially in the backward direction which occurred while walking, sitting without support and getting up from a chair. Family members reported a constant staring expression, reduced volume and output of speech, and change in behaviour—disinterest in routine activities and occasional inappropriate laughing or crying. There was no history of tremor. There was also a history of occasional difficulty swallowing liquids, choking, and spillage of food while eating. There was no family history of Parkinsonism. Though the patient was started on dopaminergic medications, there was no significant improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964;10:333–59.

    Article  CAS  PubMed  Google Scholar 

  2. Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol. 2010;23(4):394–400.

    Article  PubMed  Google Scholar 

  3. Armstrong MJ. Progressive supranuclear palsy: an update. Curr Neurol Neurosci Rep. 2018;18(3):12.

    Article  PubMed  Google Scholar 

  4. Coyle-Gilchrist IT, Dick KM, Patterson K, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016;86(18):1736–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-Parkinsonism. Brain. 2005;128(Pt 6):1247–58.

    Article  PubMed  Google Scholar 

  6. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270–9.

    Article  PubMed  Google Scholar 

  7. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  8. Hoglinger GU, Melhem NM, Dickson DW, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011;43(7):699–705.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lannuzel A, Michel PP, Caparros-Lefebvre D, et al. Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical Parkinsonism in Guadeloupe. Mov Disord. 2002;17(1):84–90.

    Article  PubMed  Google Scholar 

  10. Hoglinger GU, Lannuzel A, Khondiker ME, et al. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem. 2005;95(4):930–9.

    Article  CAS  PubMed  Google Scholar 

  11. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996;55(1):97–105.

    Article  CAS  PubMed  Google Scholar 

  12. Maher ER, Lees AJ. The clinical features and natural history of the Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology. 1986;36(7):1005–8.

    Article  CAS  PubMed  Google Scholar 

  13. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology. 1988;38(7):1031–4.

    Article  CAS  PubMed  Google Scholar 

  14. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996;60(6):615–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ling H. Clinical approach to progressive supranuclear palsy. J Mov Disord. 2016;9(1):3–13.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ling H, Massey LA, Lees AJ, Brown P, Day BL. Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain. 2012;135(Pt 4):1141–53.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Niall Q, Mikko K. Fast micrographia and pallidal pathology. Mov Disord. 2003;18(9):1067–9.

    Article  Google Scholar 

  18. Rivaud-Pechoux S, Vidailhet M, Gallouedec G, et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2000;54(5):1029–32.

    Article  CAS  PubMed  Google Scholar 

  19. Quinn N. The “round the houses” sign in progressive supranuclear palsy. Ann Neurol. 1996;40(6):951.

    Article  CAS  PubMed  Google Scholar 

  20. Troost BT, Daroff RB. The ocular motor defects in progressive supranuclear palsy. Ann Neurol. 1977;2(5):397–403.

    Article  CAS  PubMed  Google Scholar 

  21. Rafal RD, Posner MI, Friedman JH, Inhoff AW, Bernstein E. Orienting of visual attention in progressive supranuclear palsy. Brain. 1988;111(Pt 2):267–80.

    Article  PubMed  Google Scholar 

  22. Gerstenecker A, Mast B, Duff K, et al. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol. 2013;28(2):104–13.

    Article  PubMed  Google Scholar 

  23. Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl. 1994;42:69–78.

    Article  CAS  PubMed  Google Scholar 

  24. Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology. 2003;60(6):910–6.

    Article  CAS  PubMed  Google Scholar 

  25. Radicati FG, Martinez Martin P, Fossati C, et al. Non motor symptoms in progressive supranuclear palsy: prevalence and severity. NPJ Parkinsons Dis. 2017;3:35.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med. 2009;10(4):407–15.

    Article  PubMed  Google Scholar 

  27. Stamelou M, Bhatia KP. Atypical Parkinsonism: diagnosis and treatment. Neurol Clin. 2015;33(1):39–56.

    Article  PubMed  Google Scholar 

  28. Stamelou M, Quinn NP, Bhatia KP. “Atypical” atypical Parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—a diagnostic guide. Mov Disord. 2013;28(9):1184–99.

    Article  CAS  PubMed  Google Scholar 

  29. Stezin A, Lenka A, Jhunjhunwala K, Saini J, Pal PK. Advanced structural neuroimaging in progressive supranuclear palsy: where do we stand? Parkinsonism Relat Disord. 2017;36:19–32.

    Article  PubMed  Google Scholar 

  30. Longoni G, Agosta F, Kostic VS, et al. MRI measurements of brainstem structures in patients with Richardson’s syndrome, progressive supranuclear palsy-Parkinsonism, and Parkinson’s disease. Mov Disord. 2011;26(2):247–55.

    Article  PubMed  Google Scholar 

  31. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. 2003;210(1–2):57–60.

    Article  PubMed  Google Scholar 

  32. Adachi M, Kawanami T, Ohshima H, Sugai Y, Hosoya T. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci. 2004;3(3):125–32.

    Article  PubMed  Google Scholar 

  33. Boxer AL, Yu JT, Golbe LI, et al. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017;16(7):552–63.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Stamelou M, de Silva R, Arias-Carrion O, et al. Rational therapeutic approaches to progressive supranuclear palsy. Brain. 2010;133(Pt 6):1578–90.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Prasad, S., Pal, P.K. (2024). Progressive Supranuclear Palsy. In: Oli, K.K., Shrestha, G.S., Ojha, R., Pal, P.K., Pandey, S., Das, B. (eds) Case-based Approach to Common Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-8676-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-8676-7_24

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-8675-0

  • Online ISBN: 978-981-99-8676-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics